Product characterisation key to successful CAR T therapies, Autolus
CAR T-cell understanding must come before the process design if such therapies are ever going to be accessible to a larger patient population, says Autolus.
Archives for January 16, 2018
Room for another: Sandoz files Humira biosimilar in US
“There is room in most markets for a number of competitors” says Novartis as it submits its biosimilar adalimumab for review.
Sweden's Xbrane eyes partnership to bring Lucentis biosimilar to China
Swedish drugmaker Xbrane Biopharma says it is teaming with CR Pharma to bring its Lucentis (ranibizumab) biosimilar to China.